HomeABNX • EPA
add
Abionyx Pharma SA
Previous close
€1.28
Day range
€1.25 - €1.28
Year range
€0.91 - €1.50
Market cap
43.66M EUR
Avg Volume
38.68K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.17M | 10.15% |
Operating expense | 1.21M | 9.47% |
Net income | -1.04M | 7.12% |
Net profit margin | -89.08 | 15.68% |
Earnings per share | — | — |
EBITDA | -1.03M | 4.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.30M | 174.25% |
Total assets | 15.46M | 11.77% |
Total liabilities | 6.01M | -33.49% |
Total equity | 9.45M | — |
Shares outstanding | 32.46M | — |
Price to book | 4.41 | — |
Return on assets | -17.17% | — |
Return on capital | -21.04% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.04M | 7.12% |
Cash from operations | -937.00K | 26.19% |
Cash from investing | -13.50K | 61.97% |
Cash from financing | 1.55M | 528.34% |
Net change in cash | 601.50K | 156.85% |
Free cash flow | -534.69K | 29.66% |
About
Founded
2005
Website
Employees
61
